title: The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.
abstract: OBJECTIVE
  This two-part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson's disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.
  
  
  METHODS
  Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.
  
  
  CONCLUSIONS
  The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.
  
  
  CONCLUSIONS
  PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient's quality of life.
authors: Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA. snyder.charlene@mayo.edu
authors: Charlene Hoffman
authors: CH
authors: Snyder
authors: Charles H
authors: CH
authors: Adler
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy / Q000209:etiology / Q000451:nursing; D018450:Disease Progression; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology / Q000451:nursing; D009730:Nursing Assessment; D010300:Parkinson Disease / Q000188:drug therapy* / Q000451:nursing / Q000503:physiopathology / Q000523:psychology
chemical_list: D000978:Antiparkinson Agents